Stellenbosch University (SU) has announced the opening of the LaunchLab CERIBIO, a biotechnology laboratory for biotechnology startups. The initiative aims to accelerate the local biotechnology ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and billions of newly identified genes – but even this trove of data may not be e ...

Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub Newsfile - Newsfile - Mon Jun 2, 2:30AM CDT ...

Elevation Oncology, which spent the spring fending off activist investor demands to wind down, has become the latest beleaguered biotech to take up the option of a buyout from Concentra Biosciences.

10 Global Clinical Laboratory MDx Infectious Disease Markets - By Place 10.1 Hospital Lab 10.2 Outpatient Lab 10.3 Point of Care 10.4 Other Place 11 Appendices 11.1 Growth of Approved IVD Test Menu ...

A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine By David Wainer Share ...

On June 18th the institute spun out its first biotech firm, Draig Therapeutics, specialising in precision neuroscience, specifically in the treatment of depression.

Three U.S. lawmakers have disclosed recent purchases of a pet healthcare company just weeks before a biotech bill that could benefit the company's business was introduced in Congress.

Burning Rock Biotech Limited, specializing in next-generation sequencing for precision oncology, reported its financial results for Q1 2025, showing revenues of RMB133.1 million (US$18.3 million ...

Biotech firms are gaining major traction in 2025 due to the global pandemic. Take a look at some of the key features of biotech stocks before investing.

Trump’s new COVID-19 website features five arguments supporting the lab. Among them was the explanation that Wuhan – the Chinese city where the virus first began spreading – is home to a ...

Event to Discuss the Changing Landscape of HNSCC in context with the Merck KN-689 study and the Rapidly Increasing Incidences of HPV16-positive HNSCC in the United States and Europe Webinar to be ...